Xiaoxia Zuo

5.3k citations
116 papers · 2.5k indexed · h-index 29
Topics
Inflammatory Myopathies and Dermatomyositis (20 papers)Systemic Lupus Erythematosus Research (16 papers)Systemic Sclerosis and Related Diseases (15 papers)

In The Last Decade

Xiaoxia Zuo

111 papers receiving 2.5k citations

Peers

Xiaoxia Zuo
Comparison fields: 5 of 122
  • Molecular Biology 1.1k
  • Immunology 658
  • Rheumatology 576
  • Pathology and Forensic Medicine 405
  • Cancer Research 319
Replace Serafim Kiriakidis with:
Serafim Kiriakidis United Kingdom
George D. Kalliolias United States
Allan Sirsjö Sweden
Jun‐Ki Min South Korea
Markus Seifert Austria
Hyon‐Seung Yi South Korea
Nobuyoshi Kitaichi Japan
Dongyi He China
Soo‐Cheon Chae South Korea
Eun‐Ju Chang South Korea
Xiaoxia Zuo relative to Serafim Kiriakidis United Kingdom Serafim Kiriakidis's profile →
Citations per field
00.5×
Serafim Kiriakidis · 1×
Citations per year

Countries citing papers authored by Xiaoxia Zuo

Since Specialization
Citations

This map shows the geographic impact of Xiaoxia Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxia Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxia Zuo more than expected).

Fields of papers citing papers by Xiaoxia Zuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoxia Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxia Zuo. The network helps show where Xiaoxia Zuo may publish in the future.

Co-authorship network of co-authors of Xiaoxia Zuo

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoxia Zuo. A scholar is included among the top collaborators of Xiaoxia Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoxia Zuo. Xiaoxia Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 2
3 0
4 14
5 1
6 1
7 43
8 7
9 7
10 30
11 3
12 9
13 43
14 16
15 25
16 18
17 21
18 51
19 54
20 38

About Xiaoxia Zuo

Xiaoxia Zuo is a scholar working on Rheumatology, Immunology and Neurology, having authored 116 papers that have together received 2.5k indexed citations. Recurring topics across this work include Inflammatory Myopathies and Dermatomyositis (20 papers), Systemic Lupus Erythematosus Research (16 papers) and Systemic Sclerosis and Related Diseases (15 papers). The work is most often cited by research in Rheumatology (576 citations), Immunology (658 citations) and Pathology and Forensic Medicine (405 citations). Xiaoxia Zuo has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Hui Luo, Honglin Zhu, Xianzhong Xiao, Yaou Zhou, Yonghua Zheng, Huali Zhang, Peng Jin, Quan‐Zhen Li, Yisha Li and Tong Li. Their work appears in journals such as The Journal of Experimental Medicine, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026